tiprankstipranks
Trending News
More News >
Dimmi Life Holdings Limited (HK:1667)
:1667
Hong Kong Market

Dimmi Life Holdings Limited (1667) AI Stock Analysis

Compare
0 Followers

Top Page

HK:1667

Dimmi Life Holdings Limited

(1667)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
HK$0.41
▼(-4.88% Downside)
The score is held down primarily by very weak financial performance (declining revenue, deep losses, high leverage, and negative cash flows). Technicals provide a meaningful offset with strong momentum above key moving averages and a positive MACD, while valuation remains challenged due to a negative P/E and no dividend yield data.
Positive Factors
Diversified investment model
A diversified holding across healthcare, technology and consumer goods reduces single‑sector exposure and lets management reallocate capital to stronger segments. Over 2–6 months this structural breadth can stabilize cash flows and provide multiple recovery paths if one sector falters.
Multiple revenue streams
Ability to earn dividends, capital gains, management fees and partnership income provides several durable income channels. This revenue mix can produce recurring fee cash flow and upside from portfolio appreciation, supporting resilience amid operating volatility in any single subsidiary.
Positive free cash flow to net income ratio
A FCF-to-net-income ratio above 1.0 implies the company can generate free cash despite reported losses, indicating some real cash conversion. Structurally, this ability supports short‑term liquidity management and reduces immediate reliance on external financing if sustained.
Negative Factors
Declining revenue and weak margins
Material revenue contraction and deeply negative gross and net margins signal structural problems in pricing, cost control or business mix. Over months, sustained declines erode operating leverage, limit reinvestment capacity, and make recovery harder without meaningful operational turnaround.
Very high leverage and negative ROE
Extremely high debt relative to equity sharply increases financing risk and interest burden, reducing flexibility to invest or absorb shocks. Negative ROE reflects shareholder value erosion; structurally this constrains strategic options and elevates default or restructuring risk over the medium term.
Negative operating and shrinking free cash flow
Persistent operating cash deficits and steeply declining free cash flow growth indicate cash burn and weakening internal funding capacity. Over 2–6 months this forces dependence on external capital or asset sales, hampering investment in portfolio companies and long‑term value creation.

Dimmi Life Holdings Limited (1667) vs. iShares MSCI Hong Kong ETF (EWH)

Dimmi Life Holdings Limited Business Overview & Revenue Model

Company DescriptionMilestone Builder Holdings Ltd is an investment holding company principally involved in the construction business in Hong Kong. The Company’s main business is primarily engaged in the provision of building construction services, alteration, addition, fitting-out works and building services, as well as repair and restoration of historic buildings services.
How the Company Makes MoneyDimmi Life Holdings generates revenue through multiple streams, including investments in its portfolio companies, which provide dividends and capital appreciation. The company may also earn management fees from its subsidiaries and affiliated investments. Additionally, strategic partnerships with other firms in the healthcare and technology sectors may lead to joint ventures or collaborations that further enhance revenue opportunities. The company's diversified approach allows it to mitigate risks and capitalize on growth trends across various industries.

Dimmi Life Holdings Limited Financial Statement Overview

Summary
Financial health is weak: revenue declined (-14.61%), profitability is deeply negative (gross margin -7.29%, net margin -71.07%), leverage is very high (debt-to-equity 10.68, ROE -503.06%), and operating/free cash flow are negative with shrinking free cash flow (-48.06%).
Income Statement
20
Very Negative
Dimmi Life Holdings Limited has experienced declining revenue with a negative growth rate of -14.61% in the most recent year. The company has consistently reported negative margins, with the latest gross profit margin at -7.29% and net profit margin at -71.07%. These figures indicate significant challenges in achieving profitability and managing costs effectively.
Balance Sheet
25
Negative
The company's balance sheet shows a high debt-to-equity ratio of 10.68, indicating heavy reliance on debt financing. Return on equity is negative at -503.06%, reflecting substantial losses relative to shareholder equity. The equity ratio is low, suggesting potential financial instability and high leverage risk.
Cash Flow
30
Negative
Cash flow analysis reveals negative operating cash flow and free cash flow, with a free cash flow growth rate of -48.06%. The operating cash flow to net income ratio is negative, indicating cash flow challenges. However, the free cash flow to net income ratio is slightly positive at 1.01, suggesting some ability to cover net losses with free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue102.13M102.13M121.52M109.33M120.52M122.85M
Gross Profit-7.68M-7.45M2.05M4.01M-222.00K-20.52M
EBITDA-64.27M-60.38M-75.66M-12.18M-39.82M-38.54M
Net Income-72.58M-72.58M-90.42M-26.64M-60.49M-52.81M
Balance Sheet
Total Assets250.12M250.12M278.50M321.65M313.53M405.11M
Cash, Cash Equivalents and Short-Term Investments7.47M7.47M9.72M13.89M10.17M17.23M
Total Debt154.13M154.13M171.85M121.17M100.36M206.10M
Total Liabilities235.69M235.69M260.68M311.39M282.02M313.23M
Stockholders Equity14.43M14.43M17.82M10.26M31.51M91.88M
Cash Flow
Free Cash Flow-29.48M-29.48M-39.87M-20.48M-38.98M-111.12M
Operating Cash Flow-29.28M-29.28M-38.45M-20.21M-38.96M-111.07M
Investing Cash Flow-5.57M-5.57M26.00K14.77M33.06M6.64M
Financing Cash Flow32.49M32.49M34.14M8.96M-983.00K92.50M

Dimmi Life Holdings Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.43
Price Trends
50DMA
0.41
Positive
100DMA
0.36
Positive
200DMA
0.27
Positive
Market Momentum
MACD
<0.01
Positive
RSI
44.17
Neutral
STOCH
13.04
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1667, the sentiment is Positive. The current price of 0.43 is below the 20-day moving average (MA) of 0.46, above the 50-day MA of 0.41, and above the 200-day MA of 0.27, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 44.17 is Neutral, neither overbought nor oversold. The STOCH value of 13.04 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1667.

Dimmi Life Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
HK$293.92M2.4119.34%-3.12%1.92%
65
Neutral
HK$100.00M21.741.89%-20.10%-74.16%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
56
Neutral
HK$113.85M40.001.83%5.99%-74.29%
49
Neutral
HK$322.08M-8.04-23.55%10.42%11.14%
47
Neutral
HK$398.40M-7.07-346.03%-24.25%49.22%
45
Neutral
HK$105.00M15.912.37%-1.65%230.00%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1667
Dimmi Life Holdings Limited
0.42
0.18
80.43%
HK:1338
BaWang International (Group) Holding Limited
0.04
>-0.01
-20.00%
HK:6893
Hin Sang Group (International) Holding Co. Ltd.
0.30
0.04
18.00%
HK:8281
China Golden Classic Group Ltd.
0.11
>-0.01
-4.55%
HK:8436
Takbo Group Holdings Ltd.
0.25
0.06
28.87%
HK:8512
Hyfusin Group Holdings Ltd.
0.32
0.00
0.00%

Dimmi Life Holdings Limited Corporate Events

Dimmi Life Unit Signs Strategic Atomization Supply and R&D Pact, Triggers HKEX Disclosure
Jan 8, 2026

Dimmi Life Holdings’ wholly owned subsidiary Dimmi Chain has signed a strategic cooperation framework agreement with its first partner in the electronic atomization industry, under which it will act as the partner’s primary raw material supplier in China and collaborate on new technology development. The arrangement formalizes a long‑term strategic partnership aimed at optimizing resource allocation and strengthening both parties’ competitive positions, but also triggers a disclosure requirement under Hong Kong listing rules because the performance deposit Dimmi Chain must pay the partner qualifies as a significant advance to an entity relative to the group’s assets.

The most recent analyst rating on (HK:1667) stock is a Hold with a HK$0.49 price target. To see the full list of analyst forecasts on Dimmi Life Holdings Limited stock, see the HK:1667 Stock Forecast page.

Dimmi Life Holdings Reports Decreased Revenue and No Interim Dividend
Nov 28, 2025

Dimmi Life Holdings Limited reported its interim financial results for the six months ended September 30, 2025, showing a 15.3% decrease in revenue from continuing operations compared to the same period in 2024. Despite a reduction in losses from continuing operations, the company decided not to declare an interim dividend, indicating a cautious approach amidst challenging financial performance.

The most recent analyst rating on (HK:1667) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Dimmi Life Holdings Limited stock, see the HK:1667 Stock Forecast page.

Dimmi Life Holdings Schedules Board Meeting for Interim Results
Nov 13, 2025

Dimmi Life Holdings Limited has announced a board meeting scheduled for November 28, 2025, to discuss and approve the interim financial results for the six months ending September 30, 2025. The meeting will also consider the recommendation of an interim dividend, indicating the company’s commitment to maintaining shareholder value.

The most recent analyst rating on (HK:1667) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Dimmi Life Holdings Limited stock, see the HK:1667 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 08, 2026